"We listen to patients and customers and continuously develop our products," says Damian deGoa, CEO for Breas Medical.

"We now introduce a completely new version of our highly successful Vivo 50 and Vivo 60 ventilators to meet demands of customers and to further enhance treatment options and patient comfort. We call it the 'Pearl' version."

The main feature of the 'Pearl version' is the new mouthpiece ventilation (MPV) mode. Developed by the Breas R&D team, this MPV mode offers some unique advantages such as no flow between breaths, a settable apnea alarm, an adapted low-pressure alarm and clear information messages on the display.

"Our algorithm solves some of the drawbacks with MPV treatment that clinicians informed us about," says Roger Nyström, Product Manager at Breas.

The performance upgrade consists of a settable breath rate of 0bpm in MPV mode and the display of Vte and MVe when using a leak circuit.

Altogether, the 'Pearl' version widens the usage of the Vivo 50 and Vivo 60 ventilators and meets the growing demand for MPV treatment. The 'Pearl' version is available in the US, Europe and globally in countries where registration is available.  Vivo 50 and Vivo 60 ventilators in the field can be upgraded to the 'Pearl' version to make all benefits available to current patients and caregivers.

Breas Medical is one of the global leaders in Respiratory and Sleep therapy. Breas' products combine attractive Scandinavian design, excellent quality and user friendliness to enable patients with respiratory diseases to be transitioned quickly from the hospital to home.

 Breas Medical operates in more than 40 countries through a network of subsidiaries and distributors.

The Vivo 50 and Vivo 60 ventilators are life-support ventilators for use in the hospital and home environment.

The devices are recognized and appreciated for their combination of outstanding quality, intuitive user interface, extensive monitoring possibilities and robust design.